Aminkeng, Folefac; Ross, Colin J D; Rassekh, Shahrad R; Rieder, Michael J; Bhavsar, Amit P; Sanatani, Shubhayan; Bernstein, Daniel; Hayden, Michael R; Amstutz, Ursula; Carleton, Bruce C (2017). Pharmacogenomic screening for anthracycline-induced cardiotoxicity in childhood cancer. British journal of clinical pharmacology, 83(5), pp. 1143-1145. Wiley-Blackwell 10.1111/bcp.13218
![[img]](https://boris.unibe.ch/style/images/fileicons/text.png) |
Text
Aminkeng_et_al-2017-British_Journal_of_Clinical_Pharmacology.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (172kB) |
Item Type: |
Journal Article (Further Contribution) |
|---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Institute of Clinical Chemistry |
UniBE Contributor: |
Amstutz, Ursula |
Subjects: |
600 Technology > 610 Medicine & health |
ISSN: |
0306-5251 |
Publisher: |
Wiley-Blackwell |
Language: |
English |
Submitter: |
Ursula Amstutz |
Date Deposited: |
19 Feb 2018 15:35 |
Last Modified: |
05 Dec 2022 15:09 |
Publisher DOI: |
10.1111/bcp.13218 |
PubMed ID: |
28317142 |
Uncontrolled Keywords: |
anthracycline anthracycline-induced cardiotoxicity cancer chemotherapy clinical practice guidelines congestive heart failure pharmacogenomic screening |
BORIS DOI: |
10.7892/boris.108841 |
URI: |
https://boris.unibe.ch/id/eprint/108841 |
Actions (login required)
 |
Edit item |